MBIO — MUSTANG BIO, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1680048 ·
Last close
$0.40
Market Cap
$2.69M
52W High
$1.81
52W Low
$0.38
ADV30
31,052
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -1,170,000 | -1,072,000 | 15,613,000 | 15,150,000 | 8,068,000 |
| Mar 2026 | 0 | — | -1,058,000 | -955,000 | 16,582,000 | 16,258,000 | 7,986,000 |
| Dec 2025 | 0 | — | -670,000 | -538,000 | 17,593,000 | 17,266,000 | 8,064,000 |
| Sep 2025 | 0 | — | -624,000 | -468,000 | 19,361,000 | 18,984,000 | 9,590,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-4,511,000
Investing CF
$0
Financing CF
$7,004,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.56
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-400,671,000
Inventory
—
Receivables
$217,000
ST Investments
—
EBIT TTM
$-3,522,000
Pretax Income TTM
$-3,033,000
Interest Exp TTM
$1,000
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -2,432,000 | -1,921,000 | 17,593,000 | 8,064,000 | 9,529,000 | -5,264,000 |
| Dec 2024 | 0 | -12,553,000 | -15,752,000 | 9,308,000 | 13,181,000 | -3,873,000 | -11,410,000 |
| Dec 2023 | 0 | -50,726,000 | -51,602,000 | 17,742,000 | 17,619,000 | 123,000 | -49,477,000 |
| Dec 2022 | 0 | -76,159,000 | -77,525,000 | 92,422,000 | 46,149,000 | 46,273,000 | -65,066,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-2,723,000
OpCashFlow TTM
—
Assets (Latest)
$16,582,000
Forward EPS
$-0.35
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BIXT | BIOXYTRAN, INC | $2.70M | $0.02 | — |
| ONCO | Onconetix, Inc. | $2.72M | $0.62 | — |
| KAPA | Kairos Pharma, LTD. | $2.74M | $0.81 | — |
| SPRC | SciSparc Ltd. | $2.60M | $4.47 | — |
| ERNA | Ernexa Therapeutics Inc. | $2.80M | $2.40 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.